FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101740474> ?p ?o ?g. }

• W2101740474 endingPage "14" @default.
• W2101740474 startingPage "14" @default.
• W2101740474 abstract "Refractory anemia and refractory anemia with ringed sideroblasts are two myelodysplastic syndrome (MDS) subgroups linked with anemia. MDS is a group of heterogeneous oncohematological bone marrow disorders characterized by ineffective hematopoiesis, blood cytopenias, and progression of the disease toward acute myeloid leukemia. The aim of this study was to search for plasma proteome changes in MDS patients with refractory anemia and refractory anemia with ringed sideroblasts. A total of 26 patient and healthy donor plasma samples were depleted of fourteen high-abundant plasma proteins, separated with 2D electrophoresis, and statistically processed with Progenesis SameSpots software. 55 significantly differing spots were observed and corresponded to 39 different proteins identified by nanoLC-MS/MS. Changes in the fragments of the inter-alpha-trypsin inhibitor heavy chain H4 protein were observed. Using mass spectrometry-based relative label-free quantification of tryptic peptides, there were differences in alpha-2-HS-glycoprotein peptides, while no differences were observed between the control and patient sample groups for retinol-binding protein 4 peptides. This study describes plasma proteome changes associated with MDS patients with refractory anemia and refractory anemia with ringed sideroblasts. Changes observed in the inter-alpha-trypsin inhibitor heavy chain H4 fragments were in agreement with our previous studies of other MDS subgroups: refractory cytopenia with multilineage dysplasia and refractory anemia with excess blasts subtype 1. Mass spectrometry-based relative quantification of retinol-binding protein 4 peptides has shown that there are differences in the modification of this protein between refractory anemia with excess blasts subtype 1 patients and MDS patients with refractory anemia and refractory anemia with ringed sideroblasts. Alpha-2-HS-glycoprotein seems to be a new potential MDS biomarker candidate." @default.
• W2101740474 created "2016-06-24" @default.
• W2101740474 creator A5025357512 @default.
• W2101740474 creator A5029705458 @default.
• W2101740474 creator A5063889679 @default.
• W2101740474 creator A5070518027 @default.
• W2101740474 creator A5085743451 @default.
• W2101740474 creator A5086626929 @default.
• W2101740474 date "2013-01-01" @default.
• W2101740474 modified "2023-10-02" @default.
• W2101740474 title "Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome" @default.
• W2101740474 cites W1501843431 @default.
• W2101740474 cites W1559223957 @default.
• W2101740474 cites W1967244895 @default.
• W2101740474 cites W1984283460 @default.
• W2101740474 cites W1989150212 @default.
• W2101740474 cites W2004211176 @default.
• W2101740474 cites W2017415179 @default.
• W2101740474 cites W2021149219 @default.
• W2101740474 cites W2042253157 @default.
• W2101740474 cites W2044201516 @default.
• W2101740474 cites W2048040326 @default.
• W2101740474 cites W2056006158 @default.
• W2101740474 cites W2057692844 @default.
• W2101740474 cites W2081082605 @default.
• W2101740474 cites W2082700989 @default.
• W2101740474 cites W2088605851 @default.
• W2101740474 cites W2096638244 @default.
• W2101740474 cites W2100442531 @default.
• W2101740474 cites W2107710616 @default.
• W2101740474 cites W2110162690 @default.
• W2101740474 cites W2110361767 @default.
• W2101740474 cites W2119926256 @default.
• W2101740474 cites W2129865803 @default.
• W2101740474 cites W2130711483 @default.
• W2101740474 cites W2133295971 @default.
• W2101740474 cites W2137204941 @default.
• W2101740474 cites W2138191061 @default.
• W2101740474 cites W2143582844 @default.
• W2101740474 cites W2148968593 @default.
• W2101740474 cites W2152172317 @default.
• W2101740474 cites W2152893850 @default.
• W2101740474 cites W2154672825 @default.
• W2101740474 cites W2157492758 @default.
• W2101740474 cites W2159159025 @default.
• W2101740474 cites W2160321290 @default.
• W2101740474 cites W2161155162 @default.
• W2101740474 cites W2165817693 @default.
• W2101740474 cites W2274514075 @default.
• W2101740474 cites W2358730990 @default.
• W2101740474 cites W2418053809 @default.
• W2101740474 doi "https://doi.org/10.1186/1477-5956-11-14" @default.
• W2101740474 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3635902" @default.
• W2101740474 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23566303" @default.
• W2101740474 hasPublicationYear "2013" @default.
• W2101740474 type Work @default.
• W2101740474 sameAs 2101740474 @default.
• W2101740474 citedByCount "13" @default.
• W2101740474 countsByYear W21017404742014 @default.
• W2101740474 countsByYear W21017404742015 @default.
• W2101740474 countsByYear W21017404742016 @default.
• W2101740474 countsByYear W21017404742017 @default.
• W2101740474 countsByYear W21017404742018 @default.
• W2101740474 countsByYear W21017404742022 @default.
• W2101740474 crossrefType "journal-article" @default.
• W2101740474 hasAuthorship W2101740474A5025357512 @default.
• W2101740474 hasAuthorship W2101740474A5029705458 @default.
• W2101740474 hasAuthorship W2101740474A5063889679 @default.
• W2101740474 hasAuthorship W2101740474A5070518027 @default.
• W2101740474 hasAuthorship W2101740474A5085743451 @default.
• W2101740474 hasAuthorship W2101740474A5086626929 @default.
• W2101740474 hasBestOaLocation W21017404741 @default.
• W2101740474 hasConcept C104397665 @default.
• W2101740474 hasConcept C126322002 @default.
• W2101740474 hasConcept C142424586 @default.
• W2101740474 hasConcept C2778248108 @default.
• W2101740474 hasConcept C2780007613 @default.
• W2101740474 hasConcept C2780817109 @default.
• W2101740474 hasConcept C3018572732 @default.
• W2101740474 hasConcept C60644358 @default.
• W2101740474 hasConcept C71924100 @default.
• W2101740474 hasConcept C86803240 @default.
• W2101740474 hasConcept C87355193 @default.
• W2101740474 hasConcept C90924648 @default.
• W2101740474 hasConceptScore W2101740474C104397665 @default.
• W2101740474 hasConceptScore W2101740474C126322002 @default.
• W2101740474 hasConceptScore W2101740474C142424586 @default.
• W2101740474 hasConceptScore W2101740474C2778248108 @default.
• W2101740474 hasConceptScore W2101740474C2780007613 @default.
• W2101740474 hasConceptScore W2101740474C2780817109 @default.
• W2101740474 hasConceptScore W2101740474C3018572732 @default.
• W2101740474 hasConceptScore W2101740474C60644358 @default.
• W2101740474 hasConceptScore W2101740474C71924100 @default.
• W2101740474 hasConceptScore W2101740474C86803240 @default.
• W2101740474 hasConceptScore W2101740474C87355193 @default.
• W2101740474 hasConceptScore W2101740474C90924648 @default.
• W2101740474 hasIssue "1" @default.
• W2101740474 hasLocation W21017404741 @default.

• next